Development and validation of a reversed phase liquid chromatographic method for analysis of griseofulvin and impurities

Journal of Pharmaceutical and Biomedical Analysis

Volumn 80, Issue , 2013, Pages 9-17

  Kahsay, Getu ^a   Adegoke, Aremu Olajire ^b   Van Schepdael, Ann ^a   Adams, Erwin ^a  

^a UNIVERSITY OF LEUVEN   (Belgium)

^b UNIVERSITY OF IBADAN   (Nigeria)

Author keywords

Analysis; Griseofulvin; Impurities; Liquid chromatography; MS MS

Indexed keywords

DECHLOROGRISEOFULVIN; DEHYDROGRISEOFULVIN; DIHYDROGRISEOFULVIN; FORMIC ACID; GRISEOFULVIC ACID; GRISEOFULVIN; ISOGRISEOFULVIN; TETRAHYDROGRISEOFULVIN; UNCLASSIFIED DRUG; WATER;

ACCURACY; ARTICLE; EXPERIMENTAL DESIGN; FLOW RATE; LIQUID CHROMATOGRAPHY; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; PH; PRIORITY JOURNAL; QUALITY CONTROL; REVERSED PHASE LIQUID CHROMATOGRAPHY; TABLET; VALIDATION STUDY;

ANTIFUNGAL AGENTS; CHROMATOGRAPHY, REVERSE-PHASE; DRUG CONTAMINATION; GRISEOFULVIN; MASS SPECTROMETRY; MULTIVARIATE ANALYSIS; QUALITY CONTROL; REPRODUCIBILITY OF RESULTS; SENSITIVITY AND SPECIFICITY; TANDEM MASS SPECTROMETRY;

EID: 84876015850     PISSN: 07317085     EISSN: 1873264X     Source Type: Journal    
DOI: 10.1016/j.jpba.2013.02.035     Document Type: Article

References (39)

1. Develoux M., Griseofulvin Ann. Dermatol. Venereol. 2001, 128:1317-1325.
2. European Pharmacopoeia 7th edition, Vol. 2. European Directorate for the Quality of Medicines and Healthcare, Council of Europe, Strasbourg, 2011, pp. 2126-2127.
3. Townley E.R. Griseofulvin. Analytical Profiles of Drug Substances 1979, vol. 8:219-249. Academic Press, New York.
4. Garceau Y., Brisson J., Davis I., DeAngelis R.L., Hasegawa J. TLC determination of griseofulvin in plasma and 6-demethylgriseofulvin in urine. J. Pharm. Sci. 1980, 69:561-563.
5. Fischer L.J., Riegelman S. Qunatitative determination of griseofulvin and griseofulvin-4'-alcohol in plasma by fluorimetry on thin layer chromatograms. J. Chromatogr. 1966, 21:268-274.
6. Cole R.J., Kirksey J.W., Holaday C.E. Detection of griseofulvin and dechlorogriseofulvin by thin-layer chromatography and gas-liquid chromatography. Appl. Microbiol. 1970, 19:106-108.
7. Zia H., Proveaux W.J., O'Donnell J.P., Ma J.K. Chromatographic analysis of griseofulvin and metabolites in biological fluids. J. Chromatogr. 1980, 181:77-84.
8. Meyer M.C., Raghow G. High-pressure liquid chromatographic assay for griseofulvin in plasma. J. Pharm. Sci. 1979, 68:1127-1130.
9. Nation R.L., Peng G.W., Smith V., Chiou W.L. Simple, rapid and micro high-pressure liquid chromatographic determination of plasma griseofulvin levels. J. Pharm. Sci. 1978, 67:805-808.
10. Hackett L.P., Dusci L.J. Determination of griseofulvin in human serum using high-performance liquid chromatography. J. Chromatogr. 1978, 155:206-208.
11. Kreuzig F. Determination of griseofulvin in rat plasma by high performance liquid chromatography and high-performance thin-layer chromatography. J. Chromatogr. 1979, 163:322-326.
12. Kamimura H., Omi Y., Shiobara Y., Tamaki N., Katogi Y. Simultaneous determination of griseofulvin and 6-desmethylgriseofulvin in plasma by electron capture gas chromatography. J. Chromatogr. 1979, 163:271-279.
13. Schwarz H.J., Waldman B.A., Madrid V. GLC determination of griseofulvin in human plasma. J. Pharm. Sci. 1976, 65:370-372.
14. Suenaga Y., Yasukawa N. The quantitative determination of griseofulvin by gas chromatography (ECD-GC). Jpn. J. Antibiot. 1975, 28:665-668.
15. Mistri H.N., Jangid A.G., Sanyal M., Shrivastav P. Electrospray ionization LC-MS/MS validated method to quantify griseofulvin in human plasma and its application to bioequivalence study. J. Chromatogr. B 2007, 850:318-326.
16. Martin A., Jurado M., Rodriguez M., Nùñez F., Córdoba J.J. Characterization of molds from dry-cured meat products and their metabolites by micellar electrokinetic capillary electrophoresis and random amplified polymorphic DNA PCR. J. Food Prot. 2004, 67:2234-2239.
17. Petit K.E., Mondeguer F., Roquebert M.F., Biard J.F., Pouchus Y.F. Detection of griseofulvin in a marine strain of Penicillium waksmanii by ion trap mass spectrometry. J. Microbiol. Methods 2004, 58:59-65.
18. Rundberget T., Wilkins A.L. Determination of Penicillium mycotoxins in foods and feeds using liquid chromatography-mass spectrometry. J. Chromatogr. A 2002, 964:189-197.
19. Vudathala G.K., Rogers J.A. Oral bioavailability of griseofulvin from aged griseofulvin: lipid coprecipitates: in vivo studies in rats. J. Pharm. Sci. 1992, 81:1166-1169.
20. Venkataram S., Rogers J.A. Characteristics of drug-phospholipid coprecipitates II: bioavailability studies of griseofulvin in rats. J. Pharm. Sci. 1988, 77:933-936.
21. Tur K.M., Ch'ng H.-S., Baie S. Use of bioadhesive polymer to improve the bioavailability of griseofulvin. Int. J. Pharm. 1997, 148:63-71.
22. Ahmed I.S., Aboul-Einien M.H., Mohamed O.H., Farid S.F. Relative bioavailability of griseofulvin lyophilized dry emulsion tablet vs. immediate release tablet: a single-dose, randomized, open-label, six-period, crossover study in healthy adult volunteers in the fasted and fed states. Eur. J. Pharm. Sci. 2008, 35:219-225.
23. The United States Pharmacopeia USP 35/NF 30, The United States Pharmacopeial Convention 12601, Rockville, MD 20852, USA, 2012, pp. 3378-3380.
24. The International Pharmacopoeia 1981, vol. 2. WHO, Geneva, pp. 137-139. 3rd ed.
25. The International Pharmacopoeia 1981, vol. 4. WHO, Geneva, pp. 241-243. 3rd ed.
26. Holbrook A., Bailey F., Bailey G.M. A quantitative chromatographic method for the determination of purity of griseofulvin. J. Pharm. Pharmacol. 1963, 15:274T-277T.
27. Townley E., Roden P. High-performance liquid chromatographic analysis of griseofulvin in drug substance and solid dosage forms: separation of impurities and metabolites. J. Pharm. Sci. 1980, 69:523-526.
28. Thoma K., Kübler N. Photodegradation of antimycotic drugs 4. Photodegradation of flucytosine and griseofulvin. Pharmazie 1997, 52:455-463.
29. Visky D., Vander Heyden Y., Ivànyi T., Baten P., De Beer J., Noszàl B., Roets E., Massart D.L., Hoogmartens J. Characterization of revered-phase liquid chromatographic columns by chromatographic tests. Preliminary experiments and development of the protocol. Pharmaeuropa 2002, 14:288-297.
30. Ivànyi T., Vander Heyden Y., Visky D., Baten P., De Beer J., Làzàr I., Massart D.L., Roets E. Minimal number of chromatographic test parameters for the characterisation of reversed-phase liquid chromatographic stationary phases. J. Chromatogr. A 2002, 954:99-114.
31. Visky D., Vander Heyden Y., Ivànyi T., Baten P., De Beer J., Kovàcs Z., Noszàl B., Dehouck P., Roets E., Massart D.L., Hoogmartens J. Chracterisation of reversed-phase liquid chromatographic colimns by chromatographic tests: rational column classification by a minimal number of column test parametrs. J. Chromatogr. A 2003, 1012:11-29.
32. http://pharm.kuleuven.be/pharmchem/pages/ccs.html.
33. Dehouck P., Visky D., Van den Bergh G., Haghedooren E., Adams E., Kerner A., Vander Heyden Y., Massart D.L., Kovàcs Z., Noszàl B., Hoogmartens J. Facilitated column ranking and selection in reversed-phase liquid chromatographic analysis. LC-GC Eur. 2004, 17:592-601.
34. Dasu V.V., Muralidhar R.V., Panda T. Analytical techniques for griseofulvin. Bioprocess Biosyst. Eng. 2000, 22:201-204.
35. ICH, Validation of Analytical Procedures: Text and Methodology Q2 (R1), EMA, London, 2006.
36. European Medicines Agency, Guidelines on Setting Specifications for Related Impurities in Antibiotics, EMA, London, 2012.
37. Ballantine J.A., Fenwick R.G. The mass spectra of griseofulvin analogues. Characteristic fragmentation processes in the mass spectra of spiro-cyclohexenones and spiro-cyclohexanones containing the griseofulvin skeleton. Org. Mass Spectrom. 1969, 2:1145-1169.
38. Ermer J. Validation in pharmaceutical analysis. Part I: An integrated approach,. J. Pharm. Biomed. Anal. 2001, 24:755-767.
39. Ermer J., Ploss H.J. Validation in pharmaceutical analysis. Part II: Central importance of precision to establish acceptance criteria and for verifying and improving the quality of analytical data. J. Pharm. Biomed. Anal. 2005, 37:859-870.